Additionally, compound 1 also reduced the growth of various breast cancer cell lines, possibly through inhibition of the KDM5A–H3K4me3 interaction and induction of G1 phase cell cycle arrest together with cell senescence. Here, KDM5A is linked to breast carcinoma.